| Imatinib beats interferon for first-line initial CML therapy. (Chronic Myeloid Leukemia).(chronic myeloid leukemia): An article from: Internal Medicine News | Digitalby Mitchel L. Zoler (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 3 Pages | | Publication Date: | February 01, 2003 | | Sales Rank: | 7,534,467th |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on February 1, 2003. The length of the article is 842 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Imatinib beats interferon for first-line initial CML therapy. (Chronic Myeloid Leukemia).(chronic myeloid leukemia)Author: Mitchel L. ZolerPublication: Internal Medicine News (Magazine/Journal)Date: February 1, 2003Publisher: International Medical News GroupVolume: 36 Issue: 3 Page: 45(1)Article Type: Product/Service EvaluationDistributed by Thomson Gale |
|
